carbapenems has been researched along with masoprocol in 1 studies
Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (masoprocol) | Trials (masoprocol) | Recent Studies (post-2010) (masoprocol) |
---|---|---|---|---|---|
7,355 | 147 | 5,277 | 1,527 | 8 | 163 |
Protein | Taxonomy | carbapenems (IC50) | masoprocol (IC50) |
---|---|---|---|
Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 3.5 | |
Seed linoleate 13S-lipoxygenase-1 | Glycine max (soybean) | 3.5 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 3.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Deng, X; Ding, R; Feng, H; Gao, Y; Guo, Y; Liu, H; Niu, X; Qiu, J; Wang, J; Yang, M | 1 |
1 other study(ies) available for carbapenems and masoprocol
Article | Year |
---|---|
Novel metallo-β-lactamases inhibitors restore the susceptibility of carbapenems to New Delhi metallo-lactamase-1 (NDM-1)-harbouring bacteria.
Topics: Animals; Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Dexrazoxane; Masoprocol; Meropenem; Mice; Microbial Sensitivity Tests | 2024 |